Piezo-driven theramesh: A revolutionary multifaceted actuator to repair the injured spinal cord

Piezo4Spine aims to create a groundbreaking 3D bioprinted mesh therapy for spinal cord injury that enhances neural repair through targeted mechanotransduction and gene therapy.

Subsidie
€ 3.537.120
2023

Projectdetails

Introduction

Piezo4Spine aims to develop a novel multifactorial therapy for spinal cord injury (SCI) conceived as a disruptive platform enabling unprecedented multiscale actuation to drive functional neural repair by more accurately tackling SCI complexity.

Mechanotransduction

It originally relies on the pivotal role that mechanotransduction plays in the physiology and physiopathology of tissue and organ functions, never explored before for SCI.

Development of 3D Bioprinted Mesh

We will develop a 3D bioprinted mesh containing nanocarriers with therapeutic agents acting at two pivotal aspects of neural repair:

  1. Mechanotransduction
  2. Inhibitory scarring using gene therapy strategies.

Bioactive nanocarriers will be based on cutting-edge nanoparticles whose release will be electrically triggered on-demand via wireless powering.

Novel Biomaterial

Such 3D-theramesh offers a novel and exceptionally robust biomaterial for delivering agents at the lesion, controlling time and dose.

Current Advances in SCI Therapies

Current advances in SCI therapies focus on:

  • Rehabilitation
  • Cell transplantation
  • Drugs
  • Biomaterials
  • Electrical stimulation

Although these approaches lead to partial sensory/motor recovery, chronic functional deficits limit daily living activities and shorten life expectancy in SCI patients, as they fail to promote successful axon regeneration at the lesion and restore lost functions.

Multidisciplinary Consortium

By a multidisciplinary consortium combining scientific, technological, clinical, and industrial partners enriched by their interdisciplinarity, we envision overcoming limitations of current technologies.

Targeting Neural Regeneration

We aim to tackle multiple cellular targets involved in neural regeneration after SCI with a balanced combination of therapeutic interventions able to optimally promote functional recovery.

Potential Impact

These radical science-to-technology breakthroughs could enable, if successful, novel technologies and therapies for SCI and many other neural and non-neural pathologies in which some, but not necessarily all, of these targets are involved.

Gender Dimension

The gender dimension will be implemented by ensuring that findings apply to society as a whole.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 3.537.120
Totale projectbegroting€ 3.537.121

Tijdlijn

Startdatum1-1-2023
Einddatum31-12-2026
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICASpenvoerder
  • SERVICIO DE SALUD DE CASTILLA LA MANCHA
  • FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
  • UNIVERSIDADE DE COIMBRA
  • UNIVERSITE CATHOLIQUE DE LOUVAIN
  • BLACK DROP BIODRUCKER GMBH
  • ACIB GMBH

Land(en)

SpainItalyPortugalBelgiumGermanyAustria

Vergelijkbare projecten binnen EIC Pathfinder

EIC Pathfinder

"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"

The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.

€ 2.996.550
EIC Pathfinder

Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.

The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.

€ 2.744.300
EIC Pathfinder

Dynamic Spatio-Temporal Modulation of Light by Phononic Architectures

Dynamo aims to revolutionize imaging technologies by enabling simultaneous light modulation at GHz rates, enhancing processing speed and positioning Europe as a leader in optical advancements.

€ 2.552.277
EIC Pathfinder

Emerging technologies for crystal-based gamma-ray light sources

TECHNO-CLS aims to develop novel gamma-ray light sources using oriented crystals and high-energy particle beams, enhancing applications in various scientific fields through innovative technology.

€ 2.643.187

Vergelijkbare projecten uit andere regelingen

EIC Transition

BRAIN-SPINE INTERFACES TO REVERSE UPPER- AND LOWER-LIMB PARALYSIS

Developing fully-implantable brain-spine interfaces to restore movement in individuals with chronic paralysis through advanced neurosensors and neurostimulation systems.

€ 2.490.802
ERC COG

Piezoceutical biomaterial scaffolds for immunomodulatory-based myocardial repair

The PiezoMac patch aims to regenerate cardiac muscle post-myocardial infarction using optimized piezoelectric stimulation and 3D-printed designs tailored to patient-specific heart anatomy.

€ 2.579.608
EIC Transition

DRUG-ELUTING ELECTRICAL IMPLANT TO REPAIR THE SPINAL CORD

DREIMS aims to advance a novel drug-eluting electrical implant for spinal cord repair by refining its design and meeting regulatory standards for human therapeutic use.

€ 2.494.542
ERC STG

5D Electro-Mechanical Bio-Interface for Neuronal Tissue Engineering

Develop a novel 3D biomaterial for leadless electrical and mechanical modulation to enhance brain research and neuroengineering applications.

€ 1.750.000